Published in AIDS Weekly, June 8th, 2009
Napo's drug development efforts should come as welcome news for all those supporters of such a call to action and to those who suffer from the immense mortality and morbidity imposed on children from diarrheal diseases. Recent clinical trial results show that Napo's lead drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.